Celadon Pharmaceuticals Regulatory News (CEL)

Celadon Pharmaceuticals Information

This share is currently suspended. It was suspended at a price of 13.40

There is currently no data for CEL

REMOVE ADS

Share Options

31 Jul 2006 16:47

Celsis International PLC31 July 2006 Celsis International PLC Share Options 31 July 2006: Celsis International plc today announces that under the terms ofthe 2005 Share Performance Plan, Jay LeCoque, Chief Executive and ChristianMadrolle, Finance Director, have respectively been awarded 113,398 and 87,478Share Options at a price of 5p per share on 26 July 2006. These Share Options are subject to the achievement of performance criteria asdetailed in the Share Performance Plan and in the Celsis 2006 Annual Report andAccounts Remuneration Report. Enquiries:Celsis International plc Tel: 01638 600 151Christian Madrolle, Finance Director & Company SecretaryJenny Parsons, Corporate Communications Financial Dynamics Tel: 020 7831 3113David YatesAnna Keeble This information is provided by RNS The company news service from the London Stock Exchange

Date		Source	Headline
29th Jun 2023	5:30 pm	RNS	Result of AGM
5th Jun 2023	2:46 pm	RNS	Publication of Annual Report and Notice of AGM
5th Jun 2023	7:00 am	RNS	Final Results for the year ended 31 December 2022
30th May 2023	7:00 am	RNS	£7 Million Committed Credit Facility
26th May 2023	7:00 am	RNS	Notice of Results and Investor Presentation
25th May 2023	7:00 am	RNS	West Midlands Mayor Visits Celadon’s Facility
24th May 2023	7:00 am	RNS	Inaugural Supply Contract Win
29th Mar 2023	11:05 am	RNS	Second Price Monitoring Extn
29th Mar 2023	11:00 am	RNS	Price Monitoring Extension
17th Mar 2023	4:35 pm	RNS	Price Monitoring Extension
17th Mar 2023	2:05 pm	RNS	Second Price Monitoring Extn
17th Mar 2023	2:00 pm	RNS	Price Monitoring Extension
14th Mar 2023	3:01 pm	RNS	Successful Update to Home Office Licence
14th Mar 2023	2:05 pm	RNS	Second Price Monitoring Extn
14th Mar 2023	2:00 pm	RNS	Price Monitoring Extension
13th Mar 2023	4:40 pm	RNS	Second Price Monitoring Extn
13th Mar 2023	4:35 pm	RNS	Price Monitoring Extension
13th Mar 2023	9:05 am	RNS	Second Price Monitoring Extn
13th Mar 2023	9:00 am	RNS	Price Monitoring Extension
10th Mar 2023	4:40 pm	RNS	Second Price Monitoring Extn
10th Mar 2023	4:35 pm	RNS	Price Monitoring Extension
10th Mar 2023	2:05 pm	RNS	Second Price Monitoring Extn
10th Mar 2023	2:00 pm	RNS	Price Monitoring Extension
10th Feb 2023	2:15 pm	RNS	Notification of transaction by PDMR
19th Jan 2023	7:00 am	RNS	Change of Website Address
16th Jan 2023	7:00 am	RNS	Approval of GMP Registration by MHRA
13th Jan 2023	7:00 am	RNS	Update on CFO Appointment
30th Dec 2022	7:00 am	RNS	Results of Feasibility Study
22nd Dec 2022	7:00 am	RNS	Update on GMP Registration by MHRA
1st Nov 2022	7:00 am	RNS	Appointment of CFO
29th Sep 2022	7:00 am	RNS	Interim Report for six months ended 30 June 2022
12th Sep 2022	7:00 am	RNS	Notice of Results
28th Jul 2022	7:00 am	RNS	Appointment of Tessera Investment Management
27th Jun 2022	6:15 pm	RNS	Result of AGM
22nd Jun 2022	7:00 am	RNS	Business Update
31st May 2022	1:30 pm	RNS	Notice of AGM
29th Apr 2022	7:00 am	RNS	Full year results
29th Apr 2022	7:00 am	RNS	Full year results
31st Mar 2022	8:08 am	RNS	Holding(s) in Company
30th Mar 2022	4:41 pm	RNS	Second Price Monitoring Extn
30th Mar 2022	4:36 pm	RNS	Price Monitoring Extension
29th Mar 2022	8:00 am	RNS	Change of Name
7th Oct 2009	9:56 am	RNS	Holding(s) in Company
1st Oct 2009	6:29 pm	RNS	Transfers from Treasury and Admission of Shares
30th Sep 2009	10:50 am	RNS	Holding(s) in Company
24th Sep 2009	7:00 am	RNS	Closing of the Offer
9th Sep 2009	4:26 pm	RNS	Cancellation of Listing
9th Sep 2009	12:56 pm	RNS	Offer Update
4th Sep 2009	11:57 am	RNS	Director Declaration
3rd Sep 2009	7:00 am	RNS	Offer Update

Latest Share Chat

Celadon Pharmaceuticals Regulatory News (CEL)

Share Options

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending